Novaliq’s Günther Discusses New Role

Bernhard Günther, managing director and co-founder, Novaliq GmbH, tells OIS-TV about Novaliq’s new CEO, Christian Roesky, PhD. Günther will assume the role of chief innovation officer at the specialty pharmaceutical company.


Bernhard Günther

Bernhard Günther

Bernhard Günther joined Novaliq as CEO in January 2007. He has more than 20 years of experience in the field of ocular biopharmaceutics and medical devices.

View Full Profile